Recognising emotions and rehabilitation for families living with brain tumour

Not Applicable

• Conditions: Defects of emotional recognition in brain tumour (glioblastoma) patients; Mental and Behavioural Disorders

• Registration Number: ISRCTN14920547
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-30
• Last Update Posted: 19 September 2022
• Study Completion: 2024-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients:
1. Patients pre-screened as part of the CogENT and SIND studies, scoring 11 or less on the emotional recognition test within the OCS-Bridge screening tool done pre-operatively (consistent with having a deficit pre-operatively)
2. Signed Informed Consent to SCARF-BT study
3. Aged 18 years and older
4. Imaging evidence of a high-grade glioma as assessed by a neuro-oncology MDT
5. MDT and treating clinician recommend either biopsy or debulking of the tumour; 6. Patients scoring 11 or less on the emotional recognition test within the OCS-Bridge screening tool done post-operatively (consistent with having a deficit post-operatively)
7. Patients with WHO Performance status 0-2
8. Patients suitable for oncological intervention (involving radiotherapy/ chemotherapy/ combining radiotherapy and chemotherapy)
9. For Qualitative Study only: speaks fluent English as the use of interpreters can alter patients exact words
10. For Qualitative Study only: willing to participate in the interviews and/or focus groups

Carers:
1. Written informed consent
2. Family member/someone they care for with Brain Tumour who is participating in this study
3. Able and willing to complete the caregiver Quality of Life questionnaire
4. For Qualitative Study only: speaks fluent English as the use of interpreters can alter patients exact words
5. For Qualitative Study only: willing to participate in interviews and/or focus groups

Exclusion Criteria

1. Patients unable to give written consent or who lack capacity to consent
2. Patients for palliative/best supportive care only, following surgery
3. Pre-morbid developmental or acquired/traumatic neurologic disorder (e.g. autism, stroke, severe head injury or dementia/cognitive impairment)
4. Pre-morbid major psychiatric disorder (e.g., schizophrenia)
Impaired vision and/or hearing that would interfere with task participation (determined by interacting with participant on screening and medical history)
5. Patients have impairment of facial recognition (i.e. prosopagnosia) using the OCS-Bridge screening tool score of >5 on immediate assessment
6. Impaired facial recognition (i.e. prosopagnosia) using a separate test from the OCS-Bridge screening tool, where a score of =5 on immediate assessment of neutral face recognition would suggest a deficit requiring exclusion

Study & Design

• Study Type: Interventional
• Study Design: Not specified